287 related articles for article (PubMed ID: 16188972)
1. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.
Jones KS; Petrow-Sadowski C; Bertolette DC; Huang Y; Ruscetti FW
J Virol; 2005 Oct; 79(20):12692-702. PubMed ID: 16188972
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
Jones KS; Fugo K; Petrow-Sadowski C; Huang Y; Bertolette DC; Lisinski I; Cushman SW; Jacobson S; Ruscetti FW
J Virol; 2006 Sep; 80(17):8291-302. PubMed ID: 16912281
[TBL] [Abstract][Full Text] [Related]
3. The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
Jones KS; Huang YK; Chevalier SA; Afonso PV; Petrow-Sadowski C; Bertolette DC; Gessain A; Ruscetti FW; Mahieux R
J Virol; 2009 May; 83(10):5244-55. PubMed ID: 19279090
[TBL] [Abstract][Full Text] [Related]
4. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.
Piñon JD; Klasse PJ; Jassal SR; Welson S; Weber J; Brighty DW; Sattentau QJ
J Virol; 2003 Sep; 77(18):9922-30. PubMed ID: 12941902
[TBL] [Abstract][Full Text] [Related]
5. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.
Jain P; Manuel SL; Khan ZK; Ahuja J; Quann K; Wigdahl B
J Virol; 2009 Nov; 83(21):10908-21. PubMed ID: 19692463
[TBL] [Abstract][Full Text] [Related]
6. Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta.
Jones KS; Akel S; Petrow-Sadowski C; Huang Y; Bertolette DC; Ruscetti FW
J Immunol; 2005 Apr; 174(7):4262-70. PubMed ID: 15778389
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of chondroitin sulfate type E on the binding step of human T-cell leukemia virus type 1.
Jinno-Oue A; Tanaka A; Shimizu N; Mori T; Sugiura N; Kimata K; Isomura H; Hoshino H
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):621-9. PubMed ID: 23033806
[TBL] [Abstract][Full Text] [Related]
8. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
Lambert S; Bouttier M; Vassy R; Seigneuret M; Petrow-Sadowski C; Janvier S; Heveker N; Ruscetti FW; Perret G; Jones KS; Pique C
Blood; 2009 May; 113(21):5176-85. PubMed ID: 19270265
[TBL] [Abstract][Full Text] [Related]
9. Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions.
Jones KS; Nath M; Petrow-Sadowski C; Baines AC; Dambach M; Huang Y; Ruscetti FW
J Virol; 2002 Dec; 76(24):12723-34. PubMed ID: 12438598
[TBL] [Abstract][Full Text] [Related]
10. GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1.
Takenouchi N; Jones KS; Lisinski I; Fugo K; Yao K; Cushman SW; Ruscetti FW; Jacobson S
J Virol; 2007 Feb; 81(3):1506-10. PubMed ID: 17108050
[TBL] [Abstract][Full Text] [Related]
11. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
Moriuchi H; Moriuchi M
Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
[TBL] [Abstract][Full Text] [Related]
12. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.
Jones KS; Petrow-Sadowski C; Huang YK; Bertolette DC; Ruscetti FW
Nat Med; 2008 Apr; 14(4):429-36. PubMed ID: 18376405
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation.
Nath MD; Ruscetti FW; Petrow-Sadowski C; Jones KS
Blood; 2003 Apr; 101(8):3085-92. PubMed ID: 12506039
[TBL] [Abstract][Full Text] [Related]
14. Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry.
Murray MJ; Bonilla-Medrano NI; Lee QL; Oxenford SJ; Angell R; Depledge DP; Reeves MB
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941787
[TBL] [Abstract][Full Text] [Related]
15. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells.
Kinet S; Swainson L; Lavanya M; Mongellaz C; Montel-Hagen A; Craveiro M; Manel N; Battini JL; Sitbon M; Taylor N
Retrovirology; 2007 May; 4():31. PubMed ID: 17504522
[TBL] [Abstract][Full Text] [Related]
16. Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.
Hoshino H
Front Microbiol; 2012; 3():222. PubMed ID: 22737146
[TBL] [Abstract][Full Text] [Related]
17. Current concepts regarding the HTLV-1 receptor complex.
Ghez D; Lepelletier Y; Jones KS; Pique C; Hermine O
Retrovirology; 2010 Nov; 7():99. PubMed ID: 21114861
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.
Dutartre H; Clavière M; Journo C; Mahieux R
J Virol; 2016 Sep; 90(17):7607-17. PubMed ID: 27334587
[TBL] [Abstract][Full Text] [Related]
19. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
20. Neuraminidase enhances the initial steps of human T-cell leukemia virus type 1 replication.
Tanaka M; Sun B; Tezuka K; Fujisawa J; Tanaka Y; Hoshino H; Miwa M
Microbes Infect; 2010 Feb; 12(2):119-25. PubMed ID: 19892032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
